Clinical Trial Update: Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on combining henagliflozin with continuous subcutaneous insulin infusion in type 2 diabetes mellitus; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Henagliflozin (henagliflozin)
• Insulin (insulin)

Snippet

Sponsor: First Affiliated Hospital of Guangxi Medical University | Conditions: Type2diabetes | Phase 4 | Status: COMPLETED